First-Line PARP Inhibitors—Emerging Side Effects Require Caution: A Case of PARPi-Induced Pneumonitis

by Alistair McLaren, Douglas Cartwright, Ewen Ross, Patricia Roxburgh
Published 2021-08-01

Description of a Retrospective Cohort of Epithelial Ovarian Cancer Patients with Brain Metastases: Evaluation of the Role of PARP Inhibitors in this Setting

by Zena Alizzi, Patricia Roxburgh, Douglas Cartwright, Alistair McLaren, Sarah Park, Rachel Jones, Semini Greening, Emma Hudson, Clare Green, Simon Gray, Saira Khalique, Emmanouil Karteris, Marcia Hall
Published 2023-03-01

Omentum-derived matrix enables the study of metastatic ovarian cancer and stromal cell functions in a physiologically relevant environment

by Lisa J. Neilson, Douglas Cartwright, Maija Risteli, Elina M. Jokinen, Lynn McGarry, Toni Sandvik, Konstantina Nikolatou, Kelly Hodge, Samuel Atkinson, Maria Vias, Emily J. Kay, James D. Brenton, Leo M. Carlin, David M. Bryant, Tuula Salo, Sara Zanivan
Published 2023-12-01

Impact of the COVID-19 pandemic on patients with hepatocellular carcinoma in the West of Scotland: a cohort study

by Douglas Cartwright, Stephen Barclay, Adrian Stanley, Neil Lachlan, Ruth Gillespie, Ewan Forrest, Matthew Priest, Andrew Fraser, Michael Johnston, Gregory Naylor, Umberto Pisano, David Kay, Ram Kasthuri, Stuart Ballantyne, Heather Lafferty, Jeffry Evans, Karin Oien, Alistair Stewart McLaren, Johannes A Spoor, Srikanth Puttagunta, Kirsty Armstrong, Thomas R Jeffry Evans, Shouren Datta, Jennifer Milne, Rachel Swann, Adam Wimpress
Published 2023-11-01